Collegium Pharmaceutical, Inc.
COLL
$47.85
$0.340.72%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 162.93% | 395.78% | -80.72% | 34.29% | -52.39% |
| Total Depreciation and Amortization | -0.18% | 0.08% | 0.09% | 35.37% | 17.71% |
| Total Amortization of Deferred Charges | -0.89% | -0.88% | -4.00% | 17.88% | -24.69% |
| Total Other Non-Cash Items | -128.90% | -22.29% | 507.81% | -198.95% | -79.40% |
| Change in Net Operating Assets | -45.00% | 62.66% | -193.43% | 126.28% | -2,784.71% |
| Cash from Operations | 8.28% | 30.76% | -34.55% | 1,040.59% | -113.35% |
| Capital Expenditure | -189.23% | 91.85% | -40.00% | -133.61% | 9.63% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -976.49% | 67.91% | 20.64% | -159.47% | 317.91% |
| Cash from Investing | -958.94% | 69.89% | 17.70% | 95.28% | -2,695.45% |
| Total Debt Issued | -- | -- | -- | -96.22% | -- |
| Total Debt Repaid | 0.00% | 0.00% | 0.00% | 90.19% | -108.25% |
| Issuance of Common Stock | 644.16% | -85.03% | 1,089.60% | -72.10% | -89.16% |
| Repurchase of Common Stock | 96.22% | -141.03% | 58.14% | -17,719.72% | 99.65% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -1,161.26% | 95.31% | -- | -- |
| Cash from Financing | 69.37% | -91.67% | 38.86% | -127.70% | 230.49% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 54.83% | 3.28% | -35.19% | 129.01% | -95.52% |